United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Apr 9, 2026 · Filed Apr 10, 2026

On Apr 9, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$577.87 for US$5.49M under a trading plan, leaving 40,513 shares. Filed Apr 10, 2026 (Form 4).

Sold
9,500 shares
Price
US$577.87 average (US$575.04 to US$581.45)
Value
US$5.49M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 9, 2026Common StockOption exercise9,500US$146.0350,013Direct
Apr 9, 2026Common StockSale1,260US$575.0448,753Direct
Apr 9, 2026Common StockSale1,241US$575.7547,512Direct
Apr 9, 2026Common StockSale1,478US$576.6946,034Direct
Apr 9, 2026Common StockSale1,815US$577.9044,219Direct
Apr 9, 2026Common StockSale1,140US$578.8343,079Direct
Apr 9, 2026Common StockSale1,046US$580.0742,033Direct
Apr 9, 2026Common StockSale1,482US$580.8440,551Direct
Apr 9, 2026Common StockSale38US$581.4540,513Direct

Source

View original at SEC

Related